Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection
- 31 January 2004
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 198 (1) , 51-58
Abstract
The aim of this study was to evaluate the risk of liver metastases after radical surgical treatment for gastric cancer, the potential risk factors involved, and the sensitivity of serum tumor markers during followup. A total of 208 patients who had undergone curative resection for primary gastric cancer and a prospective followup protocol were studied. The association between clinicopathologic variables and hepatic recurrence was investigated using standard univariate methods and multivariate Cox regression analysis. Mean followup time (± SD) for the entire patient population was 51 ± 38 months (median 52 months) and was 88 ± 24 months (median 81 months) for disease-free patients. Recurrence of gastric cancer was documented in 109 of 208 patients (52.4%). Liver metastases were found in 28 of 208 patients (13.5%); in most of these patients (82.1%) diagnosis was made within 2 years after surgical treatment. The estimated cumulative risk of liver metastases after 5 years was 16.4%. Cox regression analysis identified lymph node involvement (adjusted relative risk [RR] = 6.28, 95% confidence interval [CI] = 2.11 to 18.70, p = 0.001), preoperative positivity for CEA, CA 19-9, or CA 72-4 (RR = 5.18, 95% CI = 1.75 to 15.37, p = 0.003), and intestinal histotype (RR = 3.08, 95% CI = 1.06 to 8.96, p = 0.039) as independent predictors of hepatic recurrence. In 27 of 28 cases hepatic recurrence was associated with an increase in CEA, CA 19-9, or CA 72-4 serum levels above the cutoff, either before or at the time of the clinical diagnosis (sensitivity 96.4%). Preoperative positivity for serum tumor markers, lymph node involvement, and intestinal histotype are risk factors for liver metastases after radical surgical treatment for gastric cancer. Postoperative measurement of serum tumor markers may be useful for an early diagnosis of hepatic recurrence during followup.Keywords
This publication has 31 references indexed in Scilit:
- Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-year follow-up studyBritish Journal of Cancer, 2001
- Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancerThe American Journal of Surgery, 2001
- Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer?The American Journal of Surgery, 2000
- Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancerBritish Journal of Surgery, 2000
- Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 2000
- Prognostic Significance of CEA, CA 19-9 and CA 72-4 Preoperative Serum Levels in Gastric CarcinomaOncology, 1999
- Recurrences and related characteristics of gastric cancerBritish Journal of Cancer, 1996
- Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinomaHuman Pathology, 1995
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992
- Pathological characteristics of gastric cancer that develop hematogenous recurrence, with special reference to the site of recurrenceJournal of Surgical Oncology, 1987